[Pharm-policy] re-investment requirements for R&D

[James Love]

Thiru and I are researching reinvestment requirements in different
countries, and would appreciate any information anyone might have. 
These would include such schemes as:

1.  Taxes on product sales or services that are targeted for R&D
investments.

2.  Linking prices to R&D objectives

3.  Mandatory reinvestment of percentage of revenues in R&D.

4.  Patent extensions or marketing exclusivity that is conditioned upon
investments.  


Or any other approaches.  

Jamie Love <love@cptech.org>


-- 
=======================================================
James Love, Director           | http://www.cptech.org
Consumer Project on Technology | mailto:love@cptech.org 
P.O. Box 19367                 | voice: 1.202.387.8030
Washington, DC 20036           | fax:   1.202.234.5176
=======================================================